Annual gross profit:
$9.45B+$877.10M(+10.23%)Summary
- As of today (August 18, 2025), VRTX annual gross profit is $9.45 billion, with the most recent change of +$877.10 million (+10.23%) on December 31, 2024.
- During the last 3 years, VRTX annual gross profit has risen by +$2.75 billion (+41.10%).
- VRTX annual gross profit is now at all-time high.
Performance
VRTX Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$2.58B+$195.40M(+8.20%)Summary
- As of today (August 18, 2025), VRTX quarterly gross profit is $2.58 billion, with the most recent change of +$195.40 million (+8.20%) on June 30, 2025.
- Over the past year, VRTX quarterly gross profit has increased by +$315.70 million (+13.95%).
- VRTX quarterly gross profit is now at all-time high.
Performance
VRTX quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$9.81B+$315.70M(+3.33%)Summary
- As of today (August 18, 2025), VRTX TTM gross profit is $9.81 billion, with the most recent change of +$315.70 million (+3.33%) on June 30, 2025.
- Over the past year, VRTX TTM gross profit has increased by +$886.20 million (+9.93%).
- VRTX TTM gross profit is now at all-time high.
Performance
VRTX TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
VRTX Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.2% | +13.9% | +9.9% |
| 3 y3 years | +41.1% | +36.5% | +34.5% |
| 5 y5 years | +163.9% | +93.3% | +108.4% |
VRTX Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.1% | at high | +36.5% | at high | +34.5% |
| 5 y | 5-year | at high | +163.9% | at high | +93.3% | at high | +108.4% |
| alltime | all time | at high | >+9999.0% | at high | +9701.2% | at high | >+9999.0% |
VRTX Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.58B(+8.2%) | $9.81B(+3.3%) |
| Mar 2025 | - | $2.38B(-3.3%) | $9.49B(+0.4%) |
| Dec 2024 | $9.45B(+10.2%) | $2.46B(+3.4%) | $9.45B(+3.4%) |
| Sep 2024 | - | $2.38B(+5.3%) | $9.14B(+2.5%) |
| Jun 2024 | - | $2.26B(-3.5%) | $8.92B(+1.0%) |
| Mar 2024 | - | $2.34B(+8.9%) | $8.84B(+3.0%) |
| Dec 2023 | $8.58B(+11.9%) | $2.15B(-0.4%) | $8.58B(+2.2%) |
| Sep 2023 | - | $2.16B(-0.7%) | $8.39B(+2.2%) |
| Jun 2023 | - | $2.18B(+4.3%) | $8.21B(+3.6%) |
| Mar 2023 | - | $2.09B(+6.0%) | $7.92B(+3.3%) |
| Dec 2022 | $7.67B(+14.4%) | $1.97B(-0.6%) | $7.67B(+2.0%) |
| Sep 2022 | - | $1.98B(+4.8%) | $7.52B(+3.1%) |
| Jun 2022 | - | $1.89B(+3.2%) | $7.29B(+4.4%) |
| Mar 2022 | - | $1.83B(+0.9%) | $6.98B(+4.2%) |
| Dec 2021 | $6.70B(+22.4%) | $1.82B(+3.6%) | $6.70B(+6.0%) |
| Sep 2021 | - | $1.75B(+10.7%) | $6.32B(+6.6%) |
| Jun 2021 | - | $1.58B(+2.2%) | $5.93B(+4.4%) |
| Mar 2021 | - | $1.55B(+7.8%) | $5.68B(+3.7%) |
| Dec 2020 | $5.47B(+52.8%) | $1.44B(+5.7%) | $5.47B(+4.1%) |
| Sep 2020 | - | $1.36B(+1.9%) | $5.26B(+11.7%) |
| Jun 2020 | - | $1.33B(-0.8%) | $4.71B(+12.9%) |
| Mar 2020 | - | $1.34B(+10.0%) | $4.17B(+16.4%) |
| Dec 2019 | $3.58B(+35.7%) | $1.22B(+51.2%) | $3.58B(+15.5%) |
| Sep 2019 | - | $807.61M(+1.3%) | $3.10B(+4.6%) |
| Jun 2019 | - | $797.32M(+5.4%) | $2.97B(+5.2%) |
| Mar 2019 | - | $756.50M(+2.0%) | $2.82B(+7.1%) |
| Dec 2018 | $2.64B(+19.2%) | $741.63M(+10.4%) | $2.63B(+7.1%) |
| Sep 2018 | - | $671.56M(+3.2%) | $2.46B(+7.3%) |
| Jun 2018 | - | $650.45M(+14.3%) | $2.29B(+8.5%) |
| Mar 2018 | - | $569.19M(+0.3%) | $2.11B(-4.5%) |
| Dec 2017 | $2.21B(+48.4%) | $567.58M(+12.3%) | $2.21B(+8.3%) |
| Sep 2017 | - | $505.29M(+7.3%) | $2.04B(+7.7%) |
| Jun 2017 | - | $470.96M(-29.5%) | $1.90B(+4.7%) |
| Mar 2017 | - | $667.73M(+67.7%) | $1.81B(+21.5%) |
| Dec 2016 | $1.49B(+64.3%) | $398.22M(+10.7%) | $1.49B(+3.1%) |
| Sep 2016 | - | $359.71M(-6.9%) | $1.45B(+6.0%) |
| Jun 2016 | - | $386.36M(+11.2%) | $1.37B(+21.0%) |
| Mar 2016 | - | $347.43M(-1.7%) | $1.13B(+25.5%) |
| Dec 2015 | $907.82M(+86.1%) | $353.52M(+27.2%) | $898.61M(+34.6%) |
| Sep 2015 | - | $277.86M(+86.2%) | $667.45M(+22.3%) |
| Jun 2015 | - | $149.22M(+26.4%) | $545.92M(+5.4%) |
| Mar 2015 | - | $118.02M(-3.5%) | $517.83M(+4.6%) |
| Dec 2014 | $487.80M(-54.9%) | $122.36M(-21.7%) | $494.89M(-29.4%) |
| Sep 2014 | - | $156.32M(+29.1%) | $701.42M(-5.1%) |
| Jun 2014 | - | $121.12M(+27.4%) | $739.46M(-17.0%) |
| Mar 2014 | - | $95.08M(-71.1%) | $891.15M(-17.6%) |
| Dec 2013 | $1.08B(-13.3%) | $328.89M(+69.2%) | $1.08B(+8.3%) |
| Sep 2013 | - | $194.36M(-28.8%) | $999.08M(-9.4%) |
| Jun 2013 | - | $272.82M(-4.5%) | $1.10B(-2.7%) |
| Mar 2013 | - | $285.63M(+16.0%) | $1.13B(-9.1%) |
| Dec 2012 | $1.25B(-6.2%) | $246.28M(-17.2%) | $1.25B(-18.7%) |
| Sep 2012 | - | $297.47M(-2.1%) | $1.53B(-17.4%) |
| Jun 2012 | - | $303.88M(-23.9%) | $1.86B(+12.3%) |
| Mar 2012 | - | $399.53M(-25.1%) | $1.65B(+25.6%) |
| Dec 2011 | $1.33B(+1227.7%) | $533.21M(-14.1%) | $1.32B(+57.2%) |
| Sep 2011 | - | $620.79M(+516.1%) | $837.97M(+262.8%) |
| Jun 2011 | - | $100.76M(+62.2%) | $230.98M(+53.1%) |
| Mar 2011 | - | $62.14M(+14.5%) | $150.84M(+50.6%) |
| Dec 2010 | $100.18M(+74.0%) | $54.27M(+293.0%) | $100.18M(+47.8%) |
| Sep 2010 | - | $13.81M(-33.0%) | $67.77M(-0.9%) |
| Jun 2010 | - | $20.62M(+79.7%) | $68.39M(+22.5%) |
| Mar 2010 | - | $11.48M(-47.5%) | $55.82M(-3.1%) |
| Dec 2009 | $57.58M(-54.9%) | $21.86M(+51.5%) | $57.58M(+3.3%) |
| Sep 2009 | - | $14.43M(+79.2%) | $55.74M(-8.3%) |
| Jun 2009 | - | $8.05M(-39.2%) | $60.77M(-44.9%) |
| Mar 2009 | - | $13.24M(-33.9%) | $110.26M(-13.6%) |
| Dec 2008 | $127.62M | $20.02M(+2.9%) | $127.62M(-13.5%) |
| Sep 2008 | - | $19.46M(-66.2%) | $147.47M(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $57.54M(+88.0%) | $158.63M(+22.9%) |
| Mar 2008 | - | $30.60M(-23.2%) | $129.03M(-18.2%) |
| Dec 2007 | $157.65M(-11.6%) | $39.87M(+30.2%) | $157.65M(-21.9%) |
| Sep 2007 | - | $30.62M(+9.6%) | $201.98M(-6.3%) |
| Jun 2007 | - | $27.94M(-52.8%) | $215.61M(+3.8%) |
| Mar 2007 | - | $59.22M(-29.7%) | $207.70M(+16.5%) |
| Dec 2006 | $178.32M(+44.4%) | $84.20M(+90.3%) | $178.32M(+20.3%) |
| Sep 2006 | - | $44.24M(+120.9%) | $148.20M(+13.7%) |
| Jun 2006 | - | $20.03M(-32.9%) | $130.34M(-2.4%) |
| Mar 2006 | - | $29.84M(-44.8%) | $133.61M(+8.2%) |
| Dec 2005 | $123.50M(+83.2%) | $54.08M(+105.0%) | $123.50M(+24.5%) |
| Sep 2005 | - | $26.38M(+13.2%) | $99.22M(+9.0%) |
| Jun 2005 | - | $23.30M(+18.1%) | $90.99M(+17.2%) |
| Mar 2005 | - | $19.74M(-33.8%) | $77.62M(+15.1%) |
| Dec 2004 | $67.43M(+58.4%) | $29.80M(+64.2%) | $67.43M(+41.6%) |
| Sep 2004 | - | $18.15M(+82.8%) | $47.62M(+10.1%) |
| Jun 2004 | - | $9.93M(+4.1%) | $43.26M(+3.2%) |
| Mar 2004 | - | $9.54M(-4.6%) | $41.91M(-3.8%) |
| Dec 2003 | $42.58M(-67.9%) | $10.00M(-27.5%) | $43.56M(-31.3%) |
| Sep 2003 | - | $13.79M(+60.9%) | $63.45M(-18.0%) |
| Jun 2003 | - | $8.58M(-23.4%) | $77.35M(-26.1%) |
| Mar 2003 | - | $11.19M(-62.5%) | $104.65M(-16.6%) |
| Dec 2002 | $132.80M(+3.9%) | $29.89M(+7.9%) | $125.51M(-4.8%) |
| Sep 2002 | - | $27.70M(-22.8%) | $131.89M(-1.5%) |
| Jun 2002 | - | $35.87M(+11.9%) | $133.90M(+15.9%) |
| Mar 2002 | - | $32.05M(-11.6%) | $115.48M(+16.5%) |
| Dec 2001 | $127.86M(+96.9%) | $36.27M(+22.1%) | $99.14M(+59.7%) |
| Sep 2001 | - | $29.70M(+70.2%) | $62.06M(+45.1%) |
| Jun 2001 | - | $17.45M(+11.1%) | $42.77M(-27.6%) |
| Mar 2001 | - | $15.71M(-2051.2%) | $59.12M(+22.8%) |
| Dec 2000 | $64.95M(+56.8%) | -$805.00K(-107.7%) | $48.14M(+117.9%) |
| Sep 2000 | - | $10.42M(-69.2%) | $22.09M(+34.1%) |
| Jun 2000 | - | $33.80M(+615.0%) | $16.47M(-322.2%) |
| Mar 2000 | - | $4.73M(-117.6%) | -$7.41M(-38.9%) |
| Dec 1999 | $41.43M(>+9900.0%) | -$26.86M(-659.0%) | -$12.14M(-182.5%) |
| Sep 1999 | - | $4.80M(-51.5%) | $14.72M(+67.2%) |
| Jun 1999 | - | $9.91M(>+9900.0%) | $8.80M(-183.9%) |
| Mar 1999 | - | $0.00(0.0%) | -$10.49M(-46.2%) |
| Dec 1998 | $0.00(-100.0%) | $0.00(-100.0%) | -$19.50M(+167.1%) |
| Sep 1998 | - | -$1.11M(-88.2%) | -$7.30M(-187.9%) |
| Jun 1998 | - | -$9.38M(+4.2%) | $8.31M(-72.9%) |
| Mar 1998 | - | -$9.01M(-173.8%) | $30.69M(-35.3%) |
| Dec 1997 | $26.34M(>+9900.0%) | $12.20M(-15.9%) | $47.40M(+3.0%) |
| Sep 1997 | - | $14.50M(+11.5%) | $46.00M(+30.7%) |
| Jun 1997 | - | $13.00M(+68.8%) | $35.20M(+34.4%) |
| Mar 1997 | - | $7.70M(-28.7%) | $26.20M(+20.2%) |
| Dec 1996 | $0.00(0.0%) | $10.80M(+191.9%) | $21.80M(+7.9%) |
| Sep 1996 | - | $3.70M(-7.5%) | $20.20M(+2.0%) |
| Jun 1996 | - | $4.00M(+21.2%) | $19.80M(-13.9%) |
| Mar 1996 | - | $3.30M(-64.1%) | $23.00M(-10.9%) |
| Dec 1995 | $0.00(0.0%) | $9.20M(+178.8%) | $25.80M(+27.1%) |
| Sep 1995 | - | $3.30M(-54.2%) | $20.30M(-16.5%) |
| Jun 1995 | - | $7.20M(+18.0%) | $24.30M(+6.6%) |
| Mar 1995 | - | $6.10M(+64.9%) | $22.80M(-1.7%) |
| Dec 1994 | $0.00(0.0%) | $3.70M(-49.3%) | $23.20M(-39.9%) |
| Sep 1994 | - | $7.30M(+28.1%) | $38.60M(+5.5%) |
| Jun 1994 | - | $5.70M(-12.3%) | $36.60M(+0.5%) |
| Mar 1994 | - | $6.50M(-66.0%) | $36.40M(+15.2%) |
| Dec 1993 | $0.00(0.0%) | $19.10M(+260.4%) | $31.60M(+122.5%) |
| Sep 1993 | - | $5.30M(-3.6%) | $14.20M(+34.0%) |
| Jun 1993 | - | $5.50M(+223.5%) | $10.60M(+158.5%) |
| Mar 1993 | - | $1.70M(0.0%) | $4.10M(+5.1%) |
| Dec 1992 | $0.00(0.0%) | $1.70M(0.0%) | $3.90M(+11.4%) |
| Sep 1992 | - | $1.70M(-270.0%) | $3.50M(+16.7%) |
| Jun 1992 | - | -$1.00M(-166.7%) | $3.00M(-43.4%) |
| Mar 1992 | - | $1.50M(+15.4%) | $5.30M(+39.5%) |
| Dec 1991 | $0.00 | $1.30M(+8.3%) | $3.80M(+52.0%) |
| Sep 1991 | - | $1.20M(-7.7%) | $2.50M(+92.3%) |
| Jun 1991 | - | $1.30M | $1.30M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual gross profit?
- What is the all time high annual gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual gross profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly gross profit?
- What is the all time high quarterly gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM gross profit?
- What is the all time high TTM gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM gross profit year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual gross profit?
The current annual gross profit of VRTX is $9.45B
What is the all time high annual gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual gross profit is $9.45B
What is Vertex Pharmaceuticals Incorporated annual gross profit year-on-year change?
Over the past year, VRTX annual gross profit has changed by +$877.10M (+10.23%)
What is Vertex Pharmaceuticals Incorporated quarterly gross profit?
The current quarterly gross profit of VRTX is $2.58B
What is the all time high quarterly gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly gross profit is $2.58B
What is Vertex Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
Over the past year, VRTX quarterly gross profit has changed by +$315.70M (+13.95%)
What is Vertex Pharmaceuticals Incorporated TTM gross profit?
The current TTM gross profit of VRTX is $9.81B
What is the all time high TTM gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM gross profit is $9.81B
What is Vertex Pharmaceuticals Incorporated TTM gross profit year-on-year change?
Over the past year, VRTX TTM gross profit has changed by +$886.20M (+9.93%)